Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Saint Louis, MO
NPI: 1447405899Primary Practice Location
MERCY HOSPITAL ST LOUIS
615 S New Ballas Rd, Saint Louis, MO
Primary Employer
Mercy Clinic Oncology, LLC
mercy.net
HQ Phone
Get M.D. Yifan's Phone Numberphone_androidMobile
Get M.D. Yifan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 190 | 378 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 111 | 278 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 66 | 69 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 47 | 47 |
| 5 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 19 | 19 |
Authors: Gu, Guangzhi, Xia, Huimin, Hu, Quanyin, Liu, Zhongyang, Jiang, Mengyin, Kang, Ting, Miao, Deyu, Tu, Yifan, Pang, Zhiqing, Song, Qingxiang, Yao, Lei, Chen, Hongzhan, Gao, Xiaoling, Chen, Jun
Journal: Biomaterials
Publication Date: 2012-10-12
Authors: Nickolas Steinauer, Carl Freter, Jinsong Zhang
Journal: Blood Adv
Authors: Yan, Han, Zhou, Qing, Wang, Yaqiong, Tu, Yifan, Zhao, Yuxin, Yu, Jie, Chen, Kuangyang, Hu, Yepeng, Zhou, Qiao, Zhang, Wen, Zheng, Chao
Journal: Cardiovasc Diabetol
Publication Date: 2024-04-25
Lead Sponsor: Agendia
Intervention / Treatment: DIAGNOSTIC_TEST: MammaPrint, BluePrint, and Full-Genome Testing
Lead Sponsor: Washington University School of Medicine
Collaborators: Pfizer
Intervention / Treatment: BIOLOGICAL: Cetuximab, DRUG: PD 0332991
